These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29248403)

  • 21. Role of T cells in the pathogenesis of atopic dermatitis.
    Ogg G
    Clin Exp Allergy; 2009 Mar; 39(3):310-6. PubMed ID: 19040465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Filaggrin and the great epidermal barrier grief.
    McGrath JA
    Australas J Dermatol; 2008 May; 49(2):67-73; quiz 73-4. PubMed ID: 18412804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Skin barrier defects in atopic dermatitis: new treatments?].
    Eigenmann PA; Hauser C; Brüggen MC
    Rev Med Suisse; 2011 Dec; 7(321):2453-6. PubMed ID: 22279864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The research for atopic dermatitis: up to date].
    Yokozeki H
    Nihon Rinsho; 2014 Aug; 72(8):1503-9. PubMed ID: 25167760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokines and Epidermal Lipid Abnormalities in Atopic Dermatitis: A Systematic Review.
    Upadhyay PR; Seminario-Vidal L; Abe B; Ghobadi C; Sims JT
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Barrier repair therapy in atopic dermatitis: an overview.
    Hon KL; Leung AK; Barankin B
    Am J Clin Dermatol; 2013 Oct; 14(5):389-99. PubMed ID: 23757122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Implications of Pruritogens in the Pathogenesis of Atopic Dermatitis.
    Wong LS; Yen YT; Lee CH
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the relevance of an in vitro reconstructed human epidermis model for drug screening in atopic dermatitis.
    Hubaux R; Bastin C; Salmon M
    Exp Dermatol; 2018 Dec; 27(12):1403-1407. PubMed ID: 30339308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endotypes of atopic dermatitis and food allergy.
    Hui-Beckman JW; Goleva E; Berdyshev E; Leung DYM
    J Allergy Clin Immunol; 2023 Jan; 151(1):26-28. PubMed ID: 36050129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced filaggrin expression is accompanied by increased Staphylococcus aureus colonization of epidermal skin models.
    van Drongelen V; Haisma EM; Out-Luiting JJ; Nibbering PH; El Ghalbzouri A
    Clin Exp Allergy; 2014 Dec; 44(12):1515-24. PubMed ID: 25352374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The integration of physiologically-targeted skin care in the management of atopic dermatitis: focus on the use of a cleanser and moisturizer system incorporating a ceramide precursor, filaggrin degradation products, and specific "skin-barrier-friendly" excipients.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2013 Jul; 12(7):s85-91. PubMed ID: 23884506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct barrier integrity phenotypes in filaggrin-related atopic eczema following sequential tape stripping and lipid profiling.
    Angelova-Fischer I; Mannheimer AC; Hinder A; Ruether A; Franke A; Neubert RH; Fischer TW; Zillikens D
    Exp Dermatol; 2011 Apr; 20(4):351-6. PubMed ID: 21410766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis.
    Werfel T; Allam JP; Biedermann T; Eyerich K; Gilles S; Guttman-Yassky E; Hoetzenecker W; Knol E; Simon HU; Wollenberg A; Bieber T; Lauener R; Schmid-Grendelmeier P; Traidl-Hoffmann C; Akdis CA
    J Allergy Clin Immunol; 2016 Aug; 138(2):336-49. PubMed ID: 27497276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of filaggrin mutations and expression in corneal specimens from patients with or without atopic dermatitis.
    Lapp T; Auw-Haedrich C; Reinhard T; Evans R; Rodríguez E; Weidinger S; Jakob T
    Int Arch Allergy Immunol; 2014; 163(1):20-4. PubMed ID: 24247645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From the morphological to the transcriptomic characterization of a compromised three-dimensional in vitro model mimicking atopic dermatitis.
    Rouaud-Tinguely P; Boudier D; Marchand L; Barruche V; Bordes S; Coppin H; Roth MP; Closs B
    Br J Dermatol; 2015 Oct; 173(4):1006-14. PubMed ID: 26147950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenesis of atopic dermatitis].
    Lang C; Kypriotou M; Christen-Zaech S
    Rev Med Suisse; 2010 Apr; 6(246):860-2, 864-5. PubMed ID: 20455383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knock-down of filaggrin does not affect lipid organization and composition in stratum corneum of reconstructed human skin equivalents.
    van Drongelen V; Alloul-Ramdhani M; Danso MO; Mieremet A; Mulder A; van Smeden J; Bouwstra JA; El Ghalbzouri A
    Exp Dermatol; 2013 Dec; 22(12):807-12. PubMed ID: 24164439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unravelling the complex genetic background of atopic dermatitis: from genetic association results towards novel therapeutic strategies.
    Hoffjan S; Stemmler S
    Arch Dermatol Res; 2015 Oct; 307(8):659-70. PubMed ID: 25693656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basics and recent advances in the pathophysiology of atopic dermatitis.
    Nakahara T; Kido-Nakahara M; Tsuji G; Furue M
    J Dermatol; 2021 Feb; 48(2):130-139. PubMed ID: 33118662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Not Available].
    Barbarot S; Aubert H
    Ann Dermatol Venereol; 2017 Jan; 144 Suppl 1():S14-S20. PubMed ID: 29221585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.